from April 2013 high] due to disappointing Q2 and lowered guidance for 2013, the mid-cap medical-devices company Teleflex [ TFX ; yield 1.7%; forward P/E 15] is attractive on valuation. 2013 is shaping up as the 4 th good year for spinoffs
We are no longer providing equity research on Teleflex TFX . We provide broad coverage of more than 1,700 companies across 91 industry groups, and we adjust our coverage as necessary based on client demand and investor interest.
balance sheet with debt, which gives Teleflex less flexibility to make future acquisitions ..... care, a segment that is not only Teleflex 's most profitable business, but ..... model discounts the dollar value of Teleflex 's future economic profits (including
acquisitions for its medical segment. Teleflex 's relatively low-margin commercial ..... with those of outside shareholders. Teleflex manufactures products ranging from ..... long term.Teleflexhttp://www. teleflex .com/investor/corporateProfile
Industrial conglomerate Teleflex TFX announced the sale of its Power Systems ..... to Fuel Systems Solutions today. Teleflex will receive $14.5 million for ..... the book value of Power Systems. Teleflex will record this difference as a
We're putting Teleflex TFX under review while we examine our assumptions.
Teleflex TFX reported first-quarter results Tuesday ..... was minimal, the results showed that Teleflex has made significant early progress integrating ..... International, acquired in late 2007. Because Teleflex paid a substantial amount for Arrow
Teleflex TFX reported third-quarter financial results ..... Sales in the third quarter were driven by Teleflex 's medical segment, which reported a ..... off to a promising start, and we think Teleflex can obtain substantial cost savings from
Teleflex TFX recently announced that it will sell three business units ..... favorable, we're maintaining our fair value estimate for Teleflex . The three commercial business units that Teleflex will sell are Teleflex Automotive, Teleflex Industrial
Teleflex TFX announced Monday that it is acquiring ..... the acquisition is value-neutral for Teleflex . We're maintaining our fair value estimate ..... nicely complements the disposable focus of Teleflex 's existing medical product business